SRR Treatment Solutions Silverman Treatment Solutions

SRR Treatment Solutions Silverman Treatment Solutions, based in Columbia, MD, is one of the SAMHSA-registered treatment programs operating in MD. The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at SRR Treatment Solutions Silverman Treatment Solutions

The care-level question matters because what a facility offers is what it can realistically treat well. The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether SRR Treatment Solutions Silverman Treatment Solutions's offerings match the clinical need.

Insurance and payment

SRR Treatment Solutions Silverman Treatment Solutions accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to SRR Treatment Solutions Silverman Treatment Solutions, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.